Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 742

1.

Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.

Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, Taffe MA.

Psychopharmacology (Berl). 2018 Jun 16. doi: 10.1007/s00213-018-4946-0. [Epub ahead of print]

PMID:
29907926
2.

Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.

Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, Montaner J, Milloy MJ.

Drug Alcohol Depend. 2018 May 29;189:90-95. doi: 10.1016/j.drugalcdep.2018.04.026. [Epub ahead of print]

PMID:
29894910
3.

HIV Incidence Among Men Who Have Sex with Men and Inject Drugs in a Canadian Setting.

Scheim AI, Nosova E, Knight R, Hayashi K, Kerr T.

AIDS Behav. 2018 Jun 6. doi: 10.1007/s10461-018-2185-3. [Epub ahead of print]

PMID:
29876756
4.

Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Cortina S, Kennedy MC, Dong H, Fairbairn N, Hayashi K, Milloy MJ, Kerr T.

Drug Alcohol Rev. 2018 Jun 5. doi: 10.1111/dar.12815. [Epub ahead of print]

PMID:
29873125
5.

Drug checking: a potential solution to the opioid overdose epidemic?

Bardwell G, Kerr T.

Subst Abuse Treat Prev Policy. 2018 May 25;13(1):20. doi: 10.1186/s13011-018-0156-3.

6.

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, Banks SL, Stinchcomb AL, Weiss F.

Neuropsychopharmacology. 2018 Mar 22. doi: 10.1038/s41386-018-0050-8. [Epub ahead of print]

PMID:
29686308
7.

Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.

Irvine MA, Buxton JA, Otterstatter M, Balshaw R, Gustafson R, Tyndall M, Kendall P, Kerr T, Gilbert M, Coombs D.

Lancet Public Health. 2018 May;3(5):e218-e225. doi: 10.1016/S2468-2667(18)30044-6. Epub 2018 Apr 18.

8.

Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imaging.

Ellegood J, Yee Y, Kerr TM, Muller CL, Blakely RD, Henkelman RM, Veenstra-VanderWeele J, Lerch JP.

Mol Autism. 2018 Apr 10;9:24. doi: 10.1186/s13229-018-0210-z. eCollection 2018.

9.

HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.

Beaulieu T, Hayashi K, Milloy MJ, Nosova E, DeBeck K, Montaner J, Kerr T, Ti L.

J Acquir Immune Defic Syndr. 2018 May 1;78(1):93-98. doi: 10.1097/QAI.0000000000001651.

PMID:
29630030
10.

Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada.

Klimas J, Nosova E, Socías E, Nolan S, Brar R, Hayashi K, Milloy MJ, Kerr T, Wood E.

Drug Alcohol Depend. 2018 May 1;186:182-186. doi: 10.1016/j.drugalcdep.2018.01.027. Epub 2018 Mar 23.

PMID:
29604525
11.

Retrospective natural history of thymidine kinase 2 deficiency.

Garone C, Taylor RW, Nascimento A, Poulton J, Fratter C, Domínguez-González C, Evans JC, Loos M, Isohanni P, Suomalainen A, Ram D, Hughes MI, McFarland R, Barca E, Lopez Gomez C, Jayawant S, Thomas ND, Manzur AY, Kleinsteuber K, Martin MA, Kerr T, Gorman GS, Sommerville EW, Chinnery PF, Hofer M, Karch C, Ralph J, Cámara Y, Madruga-Garrido M, Domínguez-Carral J, Ortez C, Emperador S, Montoya J, Chakrapani A, Kriger JF, Schoenaker R, Levin B, Thompson JLP, Long Y, Rahman S, Donati MA, DiMauro S, Hirano M.

J Med Genet. 2018 Mar 30. pii: jmedgenet-2017-105012. doi: 10.1136/jmedgenet-2017-105012. [Epub ahead of print]

12.

The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.

Ti L, Socías ME, Wood E, Milloy MJ, Nosova E, DeBeck K, Kerr T, Hayashi K.

PLoS One. 2018 Mar 26;13(3):e0194162. doi: 10.1371/journal.pone.0194162. eCollection 2018.

13.

Approach and management of checkpoint inhibitor-related immune hepatitis.

Sanjeevaiah A, Kerr T, Beg MS.

J Gastrointest Oncol. 2018 Feb;9(1):220-224. doi: 10.21037/jgo.2017.08.14.

14.

Hospitalization among street-involved youth who use illicit drugs in Vancouver, Canada: a longitudinal analysis.

Chang DC, Rieb L, Nosova E, Liu Y, Kerr T, DeBeck K.

Harm Reduct J. 2018 Mar 20;15(1):14. doi: 10.1186/s12954-018-0223-0.

15.

A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.

Mohd Salleh NA, Richardson L, Kerr T, Shoveller J, Montaner J, Kamarulzaman A, Milloy MJ.

J Addict Med. 2018 Mar 7. doi: 10.1097/ADM.0000000000000403. [Epub ahead of print]

PMID:
29521670
16.

Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city.

Kennedy MC, Scheim A, Rachlis B, Mitra S, Bardwell G, Rourke S, Kerr T.

Drug Alcohol Depend. 2018 Apr 1;185:248-252. doi: 10.1016/j.drugalcdep.2017.12.026. Epub 2018 Feb 15.

PMID:
29475198
17.

Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.

Reddon H, DeBeck K, Socias ME, Dong H, Wood E, Montaner J, Kerr T, Milloy MJ.

Drug Alcohol Rev. 2018 Mar;37(3):421-428. doi: 10.1111/dar.12667. Epub 2018 Feb 12.

PMID:
29430806
18.

Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study.

Damon W, McNeil R, Milloy MJ, Nosova E, Kerr T, Hayashi K.

J Public Health (Oxf). 2018 Feb 7. doi: 10.1093/pubmed/fdx187. [Epub ahead of print]

PMID:
29425315
19.

Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Kennedy MC, Kerr TH, Wood E, Shoveller JA, Montaner JSG, Milloy MS.

AIDS. 2018 May 15;32(8):1059-1067. doi: 10.1097/QAD.0000000000001777.

PMID:
29424782
20.

Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.

Lake S, Kerr T, Nosova E, Milloy MJ, Wood E, DeBeck K.

J Urban Health. 2018 Apr;95(2):267-277. doi: 10.1007/s11524-017-0225-3.

PMID:
29423896
21.

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Klimas J, Dong H, Fairbairn N, Socías E, Barrios R, Wood E, Kerr T, Montaner J, Milloy MJ.

Addict Sci Clin Pract. 2018 Feb 7;13(1):3. doi: 10.1186/s13722-017-0104-y.

22.

Nonmedical prescription opioid use and illegal drug use: initiation trajectory and related risks among people who use illegal drugs in Vancouver, Canada.

Cheng T, Small W, Nosova E, Hogg B, Hayashi K, Kerr T, DeBeck K.

BMC Res Notes. 2018 Jan 16;11(1):35. doi: 10.1186/s13104-018-3152-9.

23.

Exposure to Rats and Rat-Associated Leptospira and Bartonella Species Among People Who Use Drugs in an Impoverished, Inner-City Neighborhood of Vancouver, Canada.

McVea DA, Himsworth CG, Patrick DM, Lindsay LR, Kosoy M, Kerr T.

Vector Borne Zoonotic Dis. 2018 Feb;18(2):82-88. doi: 10.1089/vbz.2017.2179. Epub 2018 Jan 3.

PMID:
29298408
24.

Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

Reddon H, Ho J, DeBeck K, Milloy MJ, Liu Y, Dong H, Ahamad K, Wood E, Kerr T, Hayashi K.

J Subst Abuse Treat. 2018 Feb;85:10-16. doi: 10.1016/j.jsat.2017.11.010. Epub 2017 Nov 28.

PMID:
29291766
25.

Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.

Goldman-Hasbun J, DeBeck K, Buxton JA, Nosova E, Wood E, Kerr T.

Harm Reduct J. 2017 Dec 22;14(1):79. doi: 10.1186/s12954-017-0206-6.

26.

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Hayashi K, Dong H, Kerr T, Dobrer S, Guillemi S, Barrios R, Montaner JSG, Wood E, Milloy MJ.

J Infect Dis. 2017 Dec 27;217(1):64-68. doi: 10.1093/infdis/jix459.

PMID:
29240903
27.

Experiences with compulsory drug detention among people who inject drugs in Bangkok, Thailand: A qualitative study.

Kerr T, Small W, Ayutthaya PPN, Hayashi K.

Int J Drug Policy. 2018 Feb;52:32-38. doi: 10.1016/j.drugpo.2017.11.016. Epub 2017 Dec 9. No abstract available.

PMID:
29227881
28.

Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.

Hayashi K, Milloy MJ, Lysyshyn M, DeBeck K, Nosova E, Wood E, Kerr T.

Drug Alcohol Depend. 2018 Feb 1;183:1-6. doi: 10.1016/j.drugalcdep.2017.10.020. Epub 2017 Dec 6.

PMID:
29220642
29.

Socioeconomic factors associated with cessation of injection drug use among street-involved youth.

Chang DC, Hadland SE, Nosova E, Wood E, Kerr T, DeBeck K.

Subst Abuse Treat Prev Policy. 2017 Dec 7;12(1):50. doi: 10.1186/s13011-017-0136-z.

30.

Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting.

Reddon H, Pettes T, Wood E, Nosova E, Milloy MJ, Kerr T, Hayashi K.

Drug Alcohol Rev. 2018 Apr;37 Suppl 1:S285-S293. doi: 10.1111/dar.12631. Epub 2017 Nov 22.

PMID:
29168263
31.

The relationship between hazardous alcohol use and violence among street-involved youth.

Fairbairn N, Wood E, Dobrer S, Dong H, Kerr T, Debeck K.

Am J Addict. 2017 Dec;26(8):852-858. doi: 10.1111/ajad.12643. Epub 2017 Nov 21.

PMID:
29160606
32.

Workplace violence among female sex workers who use drugs in Vancouver, Canada: does client-targeted policing increase safety?

Prangnell A, Shannon K, Nosova E, DeBeck K, Milloy MJ, Kerr T, Hayashi K.

J Public Health Policy. 2018 Feb;39(1):86-99. doi: 10.1057/s41271-017-0098-4.

PMID:
29109517
33.

Increasing availability of illicit and prescription opioids among people who inject drugs in a Canadian setting, 2010-2014.

Ho J, DeBeck K, Milloy MJ, Dong H, Wood E, Kerr T, Hayashi K.

Am J Drug Alcohol Abuse. 2018;44(3):368-377. doi: 10.1080/00952990.2017.1376678. Epub 2017 Oct 19.

PMID:
29048952
34.

Assessing police officers' attitudes and legal knowledge on behaviors that impact HIV transmission among people who inject drugs.

Cepeda JA, Strathdee SA, Arredondo J, Mittal ML, Rocha T, Morales M, Clairgue E, Bustamante E, Abramovitz D, Artamonova I, Bañuelos A, Kerr T, Magis-Rodriguez CL, Beletsky L.

Int J Drug Policy. 2017 Dec;50:56-63. doi: 10.1016/j.drugpo.2017.09.009.

PMID:
29028564
35.

Use of on-site detoxification services co-located with a supervised injection facility.

Gaddis A, Kennedy MC, Nosova E, Milloy MJ, Hayashi K, Wood E, Kerr T.

J Subst Abuse Treat. 2017 Nov;82:1-6. doi: 10.1016/j.jsat.2017.08.003. Epub 2017 Aug 8.

PMID:
29021106
36.

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B.

J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941. Review.

37.

Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.

Hayashi K, Ti L, Ayutthaya PPN, Suwannawong P, Kaplan K, Small W, Kerr T.

Harm Reduct J. 2017 Sep 7;14(1):63. doi: 10.1186/s12954-017-0189-3.

38.

Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Kennedy MC, Karamouzian M, Kerr T.

Curr HIV/AIDS Rep. 2017 Oct;14(5):161-183. doi: 10.1007/s11904-017-0363-y. Review.

PMID:
28875422
39.

Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth.

Hadland SE, Wood E, Nosova E, Kerr T, DeBeck K.

J Adolesc Health. 2017 Nov;61(5):612-618. doi: 10.1016/j.jadohealth.2017.05.029. Epub 2017 Sep 1.

PMID:
28867353
40.

Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Ickowicz S, Wood E, Dong H, Nguyen P, Small W, Kerr T, Montaner JSG, Milloy MJ.

Drug Alcohol Depend. 2017 Nov 1;180:33-38. doi: 10.1016/j.drugalcdep.2017.07.016. Epub 2017 Aug 10.

PMID:
28865390
41.

High Willingness to Use HIV Pre-Exposure Prophylaxis Among Transgender Women in Argentina.

Zalazar V, Arístegui I, Kerr T, Marshall BDL, Romero M, Sued O, Socías ME.

Transgend Health. 2016 Dec 1;1(1):266-273. doi: 10.1089/trgh.2016.0033. eCollection 2016.

42.

Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.

Guzman J, Kerr T, Ward LM, Ma J, Oen K, Rosenberg AM, Feldman BM, Boire G, Houghton K, Dancey P, Scuccimarri R, Bruns A, Huber AM, Watanabe Duffy K, Shiff NJ, Berard RA, Levy DM, Stringer E, Morishita K, Johnson N, Cabral DA, Larché M, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Roth J, Campillo S, Benseler S, Chédeville G, Schneider R, Tse SML, Bolaria R, Gross K, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RSM, Duffy CM, Tucker LB.

Pediatr Rheumatol Online J. 2017 Aug 22;15(1):68. doi: 10.1186/s12969-017-0196-7.

44.

Chronic pain and opioid misuse: a review of reviews.

Voon P, Karamouzian M, Kerr T.

Subst Abuse Treat Prev Policy. 2017 Aug 15;12(1):36. doi: 10.1186/s13011-017-0120-7. Review.

45.

Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.

Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Milloy MJ, Kerr T, Montaner J, Wood E.

Public Health Rep. 2017 Sep/Oct;132(5):563-569. doi: 10.1177/0033354917717230. Epub 2017 Jul 27.

PMID:
28750193
46.

Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting.

Walton G, Dong H, Milloy MJ, DeBeck K, Kerr T, Wood E, Hayashi K.

Subst Abus. 2018 Jan 2;39(1):69-76. doi: 10.1080/08897077.2017.1356798. Epub 2017 Sep 18.

PMID:
28727956
47.

Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.

Mitra S, Rachlis B, Scheim A, Bardwell G, Rourke SB, Kerr T.

Harm Reduct J. 2017 Jul 14;14(1):46. doi: 10.1186/s12954-017-0174-x.

48.

Assessing support for supervised injection services among community stakeholders in London, Canada.

Bardwell G, Scheim A, Mitra S, Kerr T.

Int J Drug Policy. 2017 Oct;48:27-33. doi: 10.1016/j.drugpo.2017.05.009. Epub 2017 Jun 27.

PMID:
28666204
49.

Hepatitis C testing in Canada: don't leave baby boomers behind.

Ti L, Lima V, Hull M, Nosyk B, Joy J, Montaner J, Krajden M, Harrigan R, Kerr T, Shannon K, Wood E, Shoveller J, Ramji A, Ko HH, Yoshida E, Hall D, Barrios R.

CMAJ. 2017 Jun 26;189(25):E870-E871. doi: 10.1503/cmaj.733111. No abstract available.

PMID:
28652485
50.

Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome.

Rogers TD, Anacker AMJ, Kerr TM, Forsberg CG, Wang J, Zhang B, Veenstra-VanderWeele J.

Mol Autism. 2017 Jun 23;8:30. doi: 10.1186/s13229-017-0148-6. eCollection 2017.

Supplemental Content

Support Center